International Conference on Diabetes and Diabetic Nursing Care September 20-21, 2017 Charlotte, North Carolina, USA

Greetings!

On behalf of the citizens of Charlotte, I would like to welcome the attendees of the 2017 International Conference on Diabetes and Diabetic Nursing Care to Charlotte on September 20 – 21, 2017. We are happy that you have chosen Charlotte for this event and we trust that you will feel comfortable and at home in the Queen City.

It gives me great pleasure to share our fast-growing, dynamic, and innovative city with such a diverse and impressive group. Charlotte continues to be recognized and selected as a meeting destination by an increasing number of organizations. It is a community of pleasant tree-lined neighborhoods, parks and museums, restaurants, and sports facilities. We are especially proud to be the home of the NASCAR Hall of Fame, the Levine Center for the Arts which includes The Bechtler Museum of Modern Art, and the Harvey B. Gantt Center for African-American Arts +Culture. In addition, the activities available in our vibrant Center City mixes dining, entertainment, and cultural amenities that are distinctly Charlotte.

Again, we are pleased to have you join us in Charlotte and we welcome the opportunity to share our southern hospitality with you.

Warm regards,

Jennifer Watson Roberts

Mayor

Message-from-the-Mayor.pdf

Track 1: Diabetes Pathophysiology

Diabetes mellitus is a heterogeneous syndrome characterised by abnormalities in carbohydrate and fat metabolism. The causes of the diabetes are multifactorial and include both genomic and environmental elements that affect beta-cell function and tissue (muscle, liver, adipose tissue, and pancreas) insulin sensitivity. However, the mechanisms controlling the interplay of this impairment are unclear. The type 1 diabetes is a chronic illness characterized by the body’s inability to produce insulin due to the autoimmune destruction of the beta cells in the pancreas. Type 2 diabetes mellitus consists of an array of dysfunctions characterized by hyperglycaemia and resulting from the combination of resistance to insulin action, inadequate insulin secretion, and excessive or inappropriate glucagon secretion. 

Related conferences: 22^nd International Congress on Prevention of Diabetes and Complications October 05-06, 2017 | London, UK; VBC 2017 Auckland, New ZealandMarch 22-23, 2017; 14^th Global Diabetes Conference and Medicare Expo Rome, Italy; 19^th Asia Pacific Diabetes Conference July 20-22, 2017 | Melbourne, Australia; 16^th Global Diabetes Conference & Medicare Expo March 22-23, 2017 | Rome, Italy; 15^th International Conference on Targeting Diabetes and Novel Therapeutics Nov 6-8, 2017 | Madrid, Spain;  10^th Diabetologists Conference  July 24-26,2017 | Vancouver, Canada;  9^th International Conference on Endocrinology and Diabetes Summit September 13-14, 2017 Singapore City, Singapore; 18^th European Diabetes Congress July 17-18, 2017 | Lisbon, Portugal;  7^th European Diabetes and Endocrinology Congress February 12-13,2018 | Munich, Germany; 2^nd International Conference on Metabolic Syndrome  August 10-11, 2017 London, UK

Track 2: Diabetes and Dermatology

Diabetes mellitus is a chronic disorder of metabolic dysregulation involving the abnormal   metabolism of glucose. Diabetes has a significant impact on the healthcare costs of the Western world. Nearly all patients with diabetes eventually develop cutaneous manifestations of the disease. Cutaneous signs of the disease can heighten the suspicions of a physician regarding the diagnosis of diabetes. This article will focus on the clinical features, pathogenesis, and treatment modalities of the various dermatologic manifestations of the disease ranging from the more benign granuloma annulare to the more sinister diabetic ulcer. Cutaneous signs of DM are extremely valuable to the clinician. For example, diabetic bullae, diabetic dermopathy, necrobiosis lipoidica diabeticorum, and the scleroderma-like syndrome of waxy skin with limited joint mobility can alert the physician to the diagnosis of diabetes, eruptive xanthomas reflect the status of glucose and lipid metabolism.

Related Conferences: 15^th International Conference on Targeting Diabetes and Novel Therapeutics Nov 6-8, 2017 | Madrid, Spain; 23^rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders November 2-4, 2017 | Bangkok, Thailand;  7^th European Diabetes and Endocrinology Congress February 12-13,2018 | Munich;  Germany 2^nd International Conference on Metabolic Syndrome August 10-11, 2017 | London, UK; 10^th Diabetologists Conference July 24-26,2017 | Vancouver, Canada;  VBC 2017| Auckland, New Zealand; 22^nd International Congress on Prevention of Diabetes and Complications October 05-06, 2017 | London, UK; International Conference on Osteoporosis, Arthritis and Musculoskeletal Disorders September 21-22, 2017 | Madrid, Spain

Track 3: Diabetes and Reproduction

Diabetes mellitus DM), a condition of constant hyperglycaemia, is a noteworthy reason for genuine small scale and macro-vascular infections, influencing, hence, almost every framework in the body. Developing proof shows that oxidative anxiety is expanded in diabetes because of overproduction of receptive oxygen species (ROS) and diminished proficiency of cancer prevention agent barriers, a procedure that begins early and intensifies through the span of the infection. Amid the advancement of diabetes, oxidation of lipids, proteins and DNA increment with time. Mitochondrial DNA changes have likewise been accounted for in diabetic tissues, proposing oxidative anxiety related mitochondrial harm. Diabetes-related oxidative anxiety may likewise be the trigger for some adjustments on sexual capacity, which can likewise incorporate diminished testicular mitochondrial work. Albeit sexual clutters have been broadly examined in diabetic men, conceivable changes in the sexual capacity of diabetic ladies have just as of late gotten consideration. The commonness of sexual brokenness in diabetic men approaches half, though in diabetic ladies it is by all accounts marginally lower.

Related conferences: 12th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France; 16th Global Diabetes Conference & Medicare Expo, March 22-23 2017; 3rd Global Congress on Endocrine Disorders and Therapies,  August 24-25 2017, Toronto, Canada; 16th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy

Track 4: Advanced Treatments for Diabetes:-

Currently there are plenty number of researches going on in the field of endocrinology-diabetes as it has become a common disorder of endocrine system which is standing at a position causing huge number of deaths and made attain the response on it.The researchers are being held in a direction of early detection to the most effective advanced treatments. Advanced treatments include development of insulin pumps, insulin injections, solid dosage forms, transplantations, surgeries, targeting mst1, artificial pancreas and many more. The advances not only being held to develop new methods but to make the most effective treatment which are affordable even by the ordinary population globally.

Related conferences: 20^th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 9^th International Conference on Endocrinology and Diabetes Summit September 13-14, 2017 Singapore; 18^th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; 10th Diabetologists Conference July 24-26,2017 Vancouver, Canada; 19^th Asia Pacific Diabetes Conference July 20-22, 2017 Melbourne, Australia;7^th European Diabetes and Endocrinology Congress May 18-19,2017 Munich, Germany ; 16^th Global Diabetes Conference & Medicare Expo March 22-23, 2017 Rome, Italy; 8^th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taiwan, Taipei; 13^th World Congress on Diabetes  October 05-06, 2017 London, UK; 12^th International Conference on Endocrinology and Diabetes Summit November 06-07, 2017 Singapore.

Track 5: Diabetes and endocrinology

Endocrinology concentrates fundamentally on the endocrine organs or those organs that may bring about hormone awkwardness". These organs incorporate the pituitary, thyroid, adrenals, ovaries, testicles and pancreas. This can be a convoluted claim to fame. There are numerous organs and hormones in the body, each with their own particular occupations to do. It is a fragile compound adjust that keeps our bodies running easily with next to no exertion on our part. At the point when the adjust is vexed, genuine sicknesses and conditions can create. Diabetes is a sickness in which your body can't legitimately utilize and store glucose (a type of sugar) because of the hormonal deficiency insulin.

Related conferences: 13^rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada; 12^th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France; 9^th International Conference on Endocrinology and Diabetes Summit, September 13-14, 2017, Singapore; 8^th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taipei, Taiwan; 15^th International Conference on Targeting Diabetes and Novel Therapeutics Nov 6-8, 2017 Madrid, Spain

Track 6: Paediatric Diabetes

Paediatric diabetes is a condition in children which deals with the endocrine glands disorder, such as variations of physical growth and sexual development in childhood, diabetes and many more. Paediatric Type 1 diabetes is a chronic illness characterized by the body’s inability to produce insulin due to autoimmune destruction of the beta cells in the pancreas. Most paediatric patients with diabetes have type 1 and a lifetime dependence on exogenous insulin. It has been estimated that 20 to 25% of children newly diagnosed with type 1 diabetes are obese.  Children with type 2 diabetes are at a higher risk of cardiovascular disease and micro vascular complications. Diabetes affects about 125,000 youth in USA younger than 19 years. Each year, approximately 13,000 children are diagnosed with diabetes. Until recently, children who diagnosed with diabetes almost exclusively had type 1 diabetes. However, as the prevalence of childhood obesity has tripled in the past 30 years, there has been an accompanying increase in the prevalence of metabolic syndrome, pre-diabetes and type 2 diabetes among children.  

Related conferences: 10th Diabetologists Conference July 24-26,2017 Vancouver, Canada;7th European Diabetes and Endocrinology Congress May 18-19,2017 Munich, Germany ; 16th Global Diabetes Conference & Medicare Expo March 22-23, 2017 Rome, Italy;18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal;8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taiwan, Taipei;19th Asia Pacific Diabetes Conference July 20-22, 2017 Melbourne, Australia;23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders November 2-4, 2017 Bangkok, Thailand;12th International Conference on Endocrinology and Diabetes Summit November 06-07, 2017 Singapore

Track 7: Genetics of Diabetes

The reasons for type 1 diabetes are obscure, albeit a few hazard components have been distinguished. The danger of creating type 1 diabetes is expanded by specific variations of the HLA-DQA1, HLA-DQB1, and HLA-DRB1 qualities. HLA qualities, including HLA-DQA1, HLA-DQB1, and HLA-DRB1, have numerous varieties, and people have a specific blend of these varieties, called a haplotype. Certain HLA haplotypes are connected with a higher danger of creating type 1 diabetes, with specific blends of HLA-DQA1, HLA-DQB1, and HLA-DRB1 quality varieties bringing about the most noteworthy hazard. An inclination to create type 1 diabetes is gone through eras in families, yet the legacy example is obscure.

Related conferences: 10th Diabetologists Conference July 24-26,2017 Vancouver, Canada; 16^th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; 3^rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada; 12^th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France; 7th European Diabetes and Endocrinology Congress May 18-19,2017 Munich, Germany

Track 8: Diabetes and Immunology

Diabetes is a disorder which can be caused due to many factors among them immunity is also one of the factors. The destruction of the islet β-cell in T1D is the result of a  complex interplay between multiple players of both the innate and adaptive immune system; immunohistochemical analysis of islet inflammation from pancreata of patients with T1D obtained at autopsy indicate a mononuclear cell infiltrate in islets (termed insulitis) consisting  mainly of macrophages, B cells and T cells. Both CD4+ and CD8+ T cells are required for disease development, by destroying the insulin-producing β cells through the effector functions of Th1 cells and direct killing by cytotoxic T lymphocytes (CTLs). CTLs initiate killing by various mechanisms including the production of inflammatory cytokines such as TNF-a and IFN-g, which act synergistically with IL-1 produced by macrophages in targeting the β-cells; they also directly kill β-cells through the secretion of perforin or by apoptosis by the activation of the Fas-Fas-L pathway.

Related conferences: 9th International Conference on Endocrinology and Diabetes Summit, September 13-14, 2017, Singapore;13rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada; 12th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France; 8thInternational Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taipei, Taiwan; 15th International Conference on Targeting Diabetes and Novel Therapeutics Nov 6-8, 2017 Madrid, Spain

Track  9: Diabetes and Urology 

Diabetes can cause early onset and increased severity of these problems. Sexual and urologic complications of diabetes occur because of the damage diabetes can cause to blood vessels and nerves. Men may have difficulty with erections or ejaculation. Women may have problems with sexual response and vaginal lubrication. Urinary tract infections and bladder problems occur more often in people with diabetes. People who keep their diabetes under control can lower their risk of the early onset of these sexual and urologic problems. Both men and women with diabetes can develop sexual problems because of damage to nerves and small blood vessels. A number of clinical studies in men and women with diabetes have reported bladder instability or hypersensitivity as the most frequent finding, ranging from 39–61% of subjects.

Related conferences: 10th Diabetologists Conference July 24-26,2017 Vancouver, Canada; 12th International Conference on Endocrinology and Diabetes Summit November 06-07, 2017 Singapore; 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders November 2-4, 2017 Bangkok, Thailand; 13th World Congress on Diabetes  October 05-06, 2017 London,UK; 18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; 20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada 

Track 10: Diabetic coma

Diabetic coma is one of a life threatening complication of diabetes which causes unconsciousness. If a diabetic individual have dangerously high blood glucose levels (hyperglycaemia) or dangerously lower blood glucose levels (hypoglycaemia) can lead to a diabetic coma. The diabetic coma is very uncommon but is very dreadful, if lapsed into, a victim will be alive but may not respond purposely to sights, sounds or other types of stimulation. If left untreated diabetic coma can be fatal. The prospect of a diabetic coma is scary, but fortunately can be prevented if some of the necessitated precautions are taken.

Related conferences: 13^th World Congress on Diabetes  October 05-06, 2017 London,UK; 12^th International Conference on Endocrinology and Diabetes Summit November 06-07, 2017 Singapore;20^th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 23^rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders November 2-4, 2017 Bangkok, Thailand; 18^th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; 10^th Diabetologists Conference July 24-26,2017 Vancouver, Canada

Track 11: Gestational Diabetes

Pregnant woman who have never had diabetes before but who have high blood glucose levels during pregnancy are said to have gestational diabetes. The most prevalent reason for woman to develop diabetes is gestational diabetes. The actual reason and causes for gestational are unknown but it can have its own clues and symptoms. Hormones from the placenta help the baby develop. But these hormones also block the action of the mother's insulin in her body. This problem is called insulin resistance. This insulin resistance makes the mother’s body hard to use up the insulin and may need three times as much insulin as in the normal conditions.

Related conferences: 3rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada; 16th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; 12th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France; 20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26, 2017 Vancouver, Canada

Track 12: Diabetes and its consequences

The consequences of diabetes are simply far beyond our expectations, day-by-day there is a new risk involved. Excess of unused glucose in the blood is scattered all over the body where not supposed to be in. Thus, if the hyperglycaemia is not maintained, it can affect every organ in the body from tip to toe but with the correct treatment and recommended lifestyle changes, the onset of complications can be prevented (or) delayed. In addition to this there are the long term damages to our body which are like micro-vascular complications, macro-vascular complications, cellulitis, Alzheimer’s disease, Angiopathy, diabetic ketoacidosis, hyperosmolar coma.

Related conferences: 3rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada; 20^th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 16^th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy;  12^th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France; 18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal

Track 13: Diabetes: Nutrition and Myths

It’s very important for us to get ourselves educated about the nutrition and myths about the diabetes and help out in managing one’s own health. There’s absolutely no doubt that obesity is the main evil contributor for the diabetes and genetics also play an equal role. People even though healthy should get their blood glucose levels checked at the age of 40 and beyond time to time. Early management of obesity and unhealthy eating habits can manage people by not getting exposed to a life time disorder. Avoiding the sugar completely and depending completely on protein food is not correct. The nutrition rich food containing all the essential components can help us stay healthy even before and after get suspected by the disorder

Related conferences: 20^th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 16^th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; 3^rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada; 12^th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France

Track 14: Diabetes: Case Study and Research:-

The main aim of the diabetes is to detect the overall condition of the disorder, there are many case research studies including animal models and human models. The integrated care for diabetes mellitus in terms of the intermediate clinical and process outcomes, the evidence-based knowledge on its implementation is scarce, and insights generalizable to other settings therefore remain limited.  This study protocol provides a description of the design and methodology of a mixed methods study on the implementation of integrated care for diabetes. The aim of the proposed research is to investigate the mechanisms by which and the context in which integrated care for diabetes has been implemented, which outcomes have been achieved and how the context and mechanisms have affected the outcomes.

Related conferences: 16^th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; 3^rd Global Congress on Endocrine Disorders and Therapies, August 24-24, 2017 Toronto, Canada; 12^th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; ATTD 2017 - Advanced Technologies & Treatments for Diabetes, February 15-18 2017, Paris, France

Track 15: Business analysis

The worldwide diabetes therapeutics market is extremely alluring and has fundamentally been driven by the development in patient volume and the yearly cost of treatment. Understanding volume has been driven by the expanded rate and commonness of diabetes and the development in treatment utilization examples, for example, the sick populace, the treatment-looking for populace, the analysed populace and the remedy populace. The yearly cost of sort 2 diabetes treatment was driven by the take-up of recently affirmed drugs. GlobalData analysis shows that the global type 2 diabetes therapeutics market was worth $23.7 billion in 2011. Between 2002 and 2011, the market grew at a rate of 11.8%. By 2020, the market is expected to be worth $45.1 billion, indicating a Compound Annual Growth Rate (CAGR) of 7.4% between 2011 and 2020.

Related Conferences: 16^th Global Diabetes Conference & Medicare Expo, March 22-23 2017, Rome Italy; Diabetes Conferences, September 29- October 01, Berlin, Germany, Canada; 3^rd Global Congress on Endocrine Disorders and Therapies, August 24-25 2017, Toronto, Canada; 12^th Asia Pacific Diabetes Conference and Expo, July 24-25 2017, Melbourne, Australia; 20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada

• Diabetes Pathophysiology
• Diabetes and Dermatology
• Diabetes and Reproduction
• Advanced Treatments for Diabetes
• Diabetes and Endocrinology
• Genetics of Diabetes
• Paediatric Diabetes
• Diabetes and Immunology
• Diabetic Coma
• Gestational Diabetes
• Diabetes and Urology
• Diabetes and its Consequences
• Diabetes: Nutrition and Myths
• Diabetes: Case Study and Research
• Business Analysis

• Endocrinologists
• Doctors
• Physicians
• Researchers
• Scientists
• Diabetes Societies and Associations
• Business Professionals
• Academic Professionals
• Students

Global scenario on Diabetes

• One in 11 adults has diabetes (415 million) in 2016.
• One adult in ten will have diabetes (642 million) by 2040.
• One in seven births is affected by gestational diabetes.

• Anti-diabetic drug revenues to 2026 at overall world level, for 9 therapeutic submarkets and 31 products – assess outlooks for production, marketing and sales.
• Forecasts to 2026 for 11 national markets in the Americas, Europe and Asia – investigate developed and developing countries for demand and revenue potentials.
• Prospects for established competitors, rising companies and new entrants – explore portfolios, opinions, results, strategies, technologies and outlooks for success.
• Review of R&D pipelines – examine progress in research and development, finding technological and medical prospects.
• Analysis of what stimulates and restrains that industry and market – gauge challenges and strengths, helping you compete, gain advantages and succeed.

• Eli Lilly
• Novo Nordisk
• Merck & Co
• Sanofi
• Takeda
• AstraZeneca
• Johnson &Johnson
• Novartis
• Becton, Dickson and Company
• Business and Economics of Diabetes

• Harvard University (Cambridge, MA, USA),
• Massachusetts Institute of Technology (MIT),
• Columbia University (New York, NY, USA)
• Oxford University (Oxford, UK)
• Yale University (New Haven, CT, USA)
• McMaster University (Hamilton, ON, Canada)
• University of Basel (Basel, Switzerland)
• University of Strasbourg (Strasbourg, France)
• University of Bonn (Bonn, Germany)
• KU Leuven (Catholic University of Louvain)
• Swiss Federal Institute of Technology in Lausanne (Lausanne, Switzerland)
• University of California at Santa Barbara (Santa Barbara, CA, USA)
• Free University of Amsterdam (VU Amsterdam).
• Texas A&M University
• Top Hospitals researching on Diabetes

• Mayo clinic (Rochester, MN),
• Massachusetts General Hospital (Boston, MA)
• Cleveland Clinic (Cleveland, OH)
• Johns Hopkins Hospital (Baltimore, MD)
• USCF Medical Centre (San Francisco, CA)
• Bassetlaw Hospital – Workshop, Nottinghamshire (UK)
• Addenbrooke’s Hospital – Cambridge, Barnet General Hospital (UK)
• Cygnet Hospital Beckton (UK)
• Wooridul Spine Hospital-Seoul (South Korea)
• Fortis Memorial Research Institute (India)
• Gleneagles Medical Centre (Tanglin, Singapore)